NASDAQ:IMMP

Immutep Shares Drop as Investors Face Trial Setback, Lawsuit Date and Nasdaq Alert
····

Immutep Shares Drop as Investors Face Trial Setback, Lawsuit Date and Nasdaq Alert

Immutep Ltd’s Nasdaq ADRs fell about 5% Wednesday as new law-firm notices highlighted litigation over its failed lung-cancer trial. The stock traded at $0.4778, below the $1 minimum required by Nasdaq, which warned the company on April 30. A securities class-action lawsuit was filed covering ADR purchases from March 2025 to March 2026. Immutep reported A$110.6 million in cash at March 31.
May 20, 2026

Stock Market Today

  • Surge in Investor Demand Drives Lloyds Banking Shares Higher
    May 30, 2026, 2:12 AM EDT. Lloyds Banking Group Plc (LSE: LLOY) has become the most bought stock on AJ Bell's platform, capturing 15.91% of buyer interest, significantly outpacing the next closest stock. The bank's Q1 2026 underlying profit rose 31% to £2 billion, beating expectations, and it continued a £1.75 billion share buyback programme, purchasing £700 million in Q1 and 7.746 million shares recently from Goldman Sachs. Despite a modest share price gain of 2.93% last week versus the FTSE 100's 0.18%, the sudden surge in investor interest lacks a clear catalyst. Analysts note UK banks remain undervalued, presenting potential long-term opportunities amid global economic uncertainties.